Moderna is likely to file its vaccine next week, Morgan Stanley analysts said. Mr Bancel sold 9,000 directly owned shares and 10,000 indirectly owned shares at an average price of $91.73 starting on November 18th, according to the filing. Mr Bancel and other Moderna executives have been steadily selling off their stakes throughout the pandemic, mostly through 10b5-1 trading plans. These plans let insiders sell shares at set times and prices without facing insider trading accusations and have faced increasing scrutiny as of late. Earlier this month, Pfizer executives used such a plan to sell shares.

Source: The Irish Times November 23, 2020 16:52 UTC